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need to be conﬁrmed in enlarged samples and further analyses are
requested in order to explore speciﬁc subgroups in each diagnostic
category.
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Introduction: Psychiatric patients are a vulnerable population
group to somatic diseases, and probably to greater use of med-
ical services than the general population. Previous studies in-
form about association between anxiety disorders and several
organic illnesses, as certain heart conditions, hypertension, gastro-
intestinal, genitourinary, and musculoskeletal and migraine. Also,
patients with depression and anxiety have increased somatic symp-
toms than patients with other chronic mental illnesses [1].
Objectives: (1) To analyze the presence of somatic health
problems in a sample of patients with affective disorders and
anxiety. (2) To study differences in relation to sociodemographic
variables.
Methods: Retrospective descriptive study of psychiatric outpa-
tients with Anxiety or Depressive Disorder, treated in a Mental
Health Unit in the Clinical University Hospital in A Corun˜a
(Spain). Information was obtained from clinical records.
The sample is composed of all patients attended in a mental
health clinic in a period of 6 months (from January to June
2012) and diagnosed by a psychiatrist of Anxiety or Depressive
Disorders. N = 284.
1 − A protocol conﬁgured for sociodemographic variables,
somatic comorbidity and psychiatric variables (DSM-IV-TR di-
agnoses) was developed.
Data were collected from medical records of patients and
grouped into two categories: Affective and anxiety disorders.
2 − We performed a descriptive analysis of the sample and a
cross between quantitative variables (age) and qualitative (comor-
bidity). As statistical signiﬁcance was used analysis of variance.
For the intersection between qualitative variables (comorbidity,
sex and condition group) Chi square was used as statistical
signiﬁcance. Data were analyzed with SPSS for windows v. 17.0.
Results: The sample is composed of 284 patients (185 women
and 99 men) with an average age of 31.94 (SD 10.46). The median
age for men was 34.2 and for women is 30.9 years.
Somatic comorbidity was found in 29% of the sample.
Comorbidity among patients with affective disorders was
33.5%, higher than comorbidity in patients with anxiety disorders
that was found in 23.4%, with statistical signiﬁcance (p< 0.05).
In the whole sample, all somatic diagnoses were reported as
more prevalent among women than among men, except myocar-
dial infarction and hypertension. Nevertheless men with affective
disorder were the group that showed greater comorbidity (38%)
followed by women with the same group of disorders, without
statistical signiﬁcance.
Age was associated to comorbidity that was found more fre-
quently in older patients.
The most frequent comorbidity were digestive disorders (25%),
followed by respiratory (24%), cardiovascular (18%) and en-
docrine disorders (9%).
Conclusions: Psychiatric outpatients with affective and anxiety
disorders present frequent somatic comorbidity.
Clinicians should pay attention to somatic health problems in
patients with depression and anxiety as about one in three patients
consulting a psychiatrist for depressive or anxiety disorders also
has somatic health problems.
Active identiﬁcation and treatment of these co-occurring mental
disorders are of practical importance.
The relationship between speciﬁc somatic health problems,
as cause of anxiety or depression must be studied in future
investigations that should analyze speciﬁc depressive and anxiety
disorders as risk factors for the development of somatic disorders.
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Objective: Patients diagnosed with a psychotic disorder and their
ﬁrst-degree relatives display increased reactivity to stress [1].
Theory predicts that experience of psychosocial stress is associ-
ated both with ventromedial prefrontal and mesolimbic dopamine
neurotransmission.
However, while there is evidence of aberrant striatal dopamine
processing in psychotic disorder, the role of the prefrontal cortex
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remains under-researched. The current study aimed at investi-
gating stress-induced in vivo dopamine release in ventromedial
prefrontal cortex (vmPFC) of individuals at familial risk for
psychosis.
It was hypothesized that ﬁrst-degree relatives would dis-
play impaired prefrontal regulation of stress-induced mesolimbic
dopamine release, reﬂected by attenuated stress-induced vmPFC
dopamine signaling associated with psychotic reactivity to the
laboratory stressor.
Method: 14 healthy ﬁrst-degree relatives (7 siblings, 6 parents,
and 1 child) of patients with a diagnosis of psychotic disorder
and 10 control subjects underwent a single dynamic PET scanning
session after intravenous administration of 183.2 (SD= 7.6) MBq
[18F]fallypride, a high afﬁnity dopamine D2/3 radioligand.
Psychosocial stress was initiated at 100 minutes postinjection
using the Montreal Imaging Stress Task [2] − a computerized
mental arithmetic task with social evaluative threat components.
PET data were analyzed using the linearized simpliﬁed refer-
ence region model.
Regression analyses were performed to compare the spatial
extent of task-related ligand displacement between control sub-
jects and relatives, and how it related to self-rated experiences of
psychosocial stress and psychosis.
Results: No large or signiﬁcant sociodemographic differences,
nor differences in subclinical psychopathology were observed
between groups. Mean levels of vmPFC baseline nondisplaceable
binding potential (BPND), task induced stress, psychosis, and spa-
tial extent of [18F]fallypride ligand displacement in vmPFC were
similar between groups. The stress condition was experienced as
signiﬁcantly more stressful compared to the control condition,
reﬂected by higher scores on the subjective stress scale.
Individuals at familial risk for psychosis displayed attenuated
dopamine stress processing in ventromedial prefrontal cortex
(vmPFC), a brain region previously identiﬁed to play a key role in
human dopaminergic stress regulation [3]. Furthermore, increased
levels of subjectively rated stress were associated with increased
intensity of psychotic experiences. This effect was particularly
pronounced in ﬁrst-degree relatives, ﬁtting previously reported
associations between abnormal dopamine reactivity and increased
stress reactivity in the daily life of subjects at familial risk of
developing psychosis.
Conclusion: Although previous studies have hypothesized a
role for prefrontal dopamine dysfunction in psychosis, this study,
to our knowledge, is the ﬁrst in vivo human imaging study
showing attenuated (i.e., hyporeactive) dopamine stress neuro-
modulation in vmPFC of individuals at familial risk for psy-
chosis. Development of high afﬁnity D2/3 radioligands, among
which [18F]fallypride, and advances in PET-methodology offer
possibilities for further exploration of extrastriatal dopamine sites
suggested to be involved in the pathophysiology of psychosis.
The work presented in the current study is at an early stage,
and there is an urgent need for further human in vivo studies
aimed at clarifying mechanisms of pathophysiological dopamine
communication between cortical and subcortical brain regions in
the context of psychosis.
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In the etiopathology of depression an important role plays un-
balance of monoaminergic transmission in the brain. In treat-
ment of depression are used drugs which selectively inhibit the
neuronal reuptake of serotonin and noradrenaline. Unfortunately,
medicines are till now have shown poor therapeutic efﬁciency.
Thus there is an urgent medical need for a better, more effective
pharmacotherapy. Citalopram is in the class of drugs called
selective serotonin reuptake inhibitors (SSRI). Since uptake is
an important mechanism for removing released neurotransmitters
and terminating their actions on adjacent nerves, the reduced
uptake caused by citalopram results in more free serotonin in
the brain to stimulate nerve cells. 1-Methyl-1,2,3,4-tetrahydro-
isoquinoline (1MeTIQ) is an endogenous substance which is
present in the human and mammalian brain. As we have shown
previously, this compound exhibits neuroprotective, antiaddictive
and MAO-inhibiting properties [1,3]. 1MeTIQ strongly affects on
the dopamine metabolism, blocks the oxidation pathway and shifts
the dopamine catabolism toward the O-methylation route. Due to
this properties, 1MeTIQ was proposed as an endogenous regulator
of dopaminergic and serotoninergic activity. In the present study
we tested antidepressant-like effects of 1MeTIQ, Citalopram and
co-administration of these drugs in the modiﬁed forced swimming
test (FST) [2] in rat. Additionally, in the neurochemical studies
the rate of dopamine (DA), serotonin (5-HT) and noradrenaline
(NA) metabolism were established after behavioral experiments in
different brain structures (hypothalamus, striatum, frontal cortex)
by HPLC methodology. The data were analyzed by means of a
two-way ANOVA followed by Duncan’s test.
Results: The FST data has shown that 1MeTIQ in a low dose
15mg/kg i.p evoked antidepressant-like effects, and signiﬁcantly
reduced the immobility time (P< 0.01) and concurrently produced
an increase of a climbing time in rat (P< 0.05). Acute admin-
istration of citalopram, (20mg/kg i.p.) also induced signiﬁcant
reduction of immobility time (P< 0.01) in FST to comparison
of saline group with simultaneously elevation of swimming time
(P< 0.01). The combined administration of citalopram and 1Me-
TIQ enhanced the antidepressant activity and signiﬁcantly reduced
immobility time in the FST. The neurochemical data demonstrated
that 1MeTIQ produced a clear and signiﬁcant elevation the rate
of noradrenaline and dopamine metabolism in frontal cortex,
striatum and hypothalamus (P< 0.01). In the same time, the rate
of serotonin metabolism was signiﬁcantly decrease by acute dose
of 1MeTIQ as well as citalopram (P< 0.01). Co-administration of
these compounds intensiﬁed the effects of 1MeTIQ and citalopram
and results in a signiﬁcant increase in the rate of dopamine and
noradrenaline metabolism (P< 0.01) while a signiﬁcant decrease
in the rate of serotonin metabolism (P< 0.01).
